Picard Medical, Inc. 8-K/A

What Happened

• Picard Medical, Inc. announced that on June 23, 2026 the Board appointed Dr. Joe Xiao as a director. The company filed an Amendment No. 1 to its June 26, 2026 Form 8-K to correct and supplement the original disclosure regarding his committee assignments.
• In connection with his appointment, Dr. Xiao was named to the Board’s Compensation Committee and the Nominating and Corporate Governance Committee, entered the company’s standard director indemnification agreement, and will be paid under the company’s existing non-employee director compensation policy (as described in PMI’s proxy filed June 15, 2026).

Key Details

• Appointment effective date: June 23, 2026.
• Committees: Compensation Committee; Nominating and Corporate Governance Committee.
• Governance: Dr. Xiao executed PMI’s standard director indemnification agreement.
• No related-party arrangements or transactions requiring Item 404(a) disclosure were reported.

Why It Matters

• This filing informs investors about a board change and clarifies Dr. Xiao’s committee roles, which affect governance oversight (compensation and director nomination/governance). The company confirms standard indemnification and routine director pay; there are no disclosed related-party issues tied to his appointment.